7. Diabetes Technology: Standards of Medical Care in Diabetes—2020
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc20-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc20-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · cited 1×
“A variety of metrics have been proposed (26) and are discussed in Section”
BackgroundContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623 · cited 1×
“8%, no reduction in A1C was seen; however, the time spent in a hypoglycemic range was reduced by 43% (51).”
BackgroundParkes, J. L., Slatin, S. L., Pardo, S., & Ginsberg, B. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1143 · Cited by 620
Garg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Miller, K. M., Beck, R. W., Bergenstal, R. M., Goland, R. S., Haller, M. J., McGill, J. B., Rodriguez, H., Simmons, J. H., Hirsch, I. B., & for the T1D Exchange Clinic Network (2013) · Diabetes Care · doi:10.2337/dc12-1770 · Cited by 505
the SWITCH Study Group, Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., & Bolinder, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2708-9 · Cited by 494
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493
Rosenstock, J., Davies, M., Home, P. D., Larsen, J., Koenen, C., & Schernthaner, G. (2008) · Diabetologia · doi:10.1007/s00125-007-0911-x · Cited by 447 · cited 1×
“However, for patients using basal insulin, assessing fasting glucose with SMBG to inform dose adjustments to achieve blood glucose targets results in lower A1C (8,9).”
BackgroundTauschmann, M., Thabit, H., Bally, L., Allen, J. M., Hartnell, S., Wilinska, M. E., Ruan, Y., Sibayan, J., Kollman, C., Cheng, P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31947-0 · Cited by 440
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S. (2011) · Diabetes Care · doi:10.2337/dc10-1732 · Cited by 429
Farmer, A., Wade, A., Goyder, E., Yudkin, P., French, D., Craven, A., Holman, R., Kinmonth, A.-L., & Neil, A. (2007) · BMJ · doi:10.1136/bmj.39247.447431.be · Cited by 407
The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
van Beers, C. A. J., DeVries, J. H., Kleijer, S. J., Smits, M. M., Geelhoed-Duijvestijn, P. H., Kramer, M. H. H., Diamant, M., Snoek, F. J., & Serné, E. H. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30193-0 · Cited by 386 · cited 1×
“risk for episodes of hypoglycemia (35),”
Jeitler, K., Horvath, K., Berghold, A., Gratzer, T. W., Neeser, K., Pieber, T. R., & Siebenhofer, A. (2008) · Diabetologia · doi:10.1007/s00125-008-0974-3 · Cited by 375
Doyle (Boland), E. A., Weinzimer, S. A., Steffen, A. T., Ahern, J. A. H., Vincent, M., & Tamborlane, W. V. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1554 · Cited by 373 · cited 14×
“There is also evidence that CSII may reduce DKA risk (109,114) and diabetes complications, in particular, retinopathy and peripheral neuropathy in youth, compared with MDI (62).”
BackgroundInfluentialRacial-ethnic disparities in management and outcomes among children with type 1 diabetes
Willi, S. M., Miller, K. M., DiMeglio, L. A., Klingensmith, G. J., Simmons, J. H., Tamborlane, W. V., Nadeau, K. J., Kittelsrud, J. M., Huckfeldt, P., Beck, R. W., et al. (2015) · Pediatrics · doi:10.1542/peds.2014-1774 · Cited by 367
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
Malanda, U. L., Welschen, L. M., Riphagen, I. I., Dekker, J. M., Nijpels, G., & Bot, S. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005060.pub3 · Cited by 358
Ziegler, R., Heidtmann, B., Hilgard, D., Hofer, S., Rosenbauer, J., Holl, R., & DPV-Wiss-Initiative, F. T. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00650.x · Cited by 334
Aleppo, G., Ruedy, K. J., Riddlesworth, T. D., Kruger, D. F., Peters, A. L., Hirsch, I., Bergenstal, R. M., Toschi, E., Ahmann, A. J., Shah, V. N., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2482 · Cited by 329
O’Kane, M. J., Bunting, B., Copeland, M., & Coates, V. E. (2008) · BMJ · doi:10.1136/bmj.39534.571644.be · Cited by 326
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Fleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetes Care · doi:10.2337/dci19-0062 · Cited by 306
Peters, A. L., Ahmann, A. J., Battelino, T., Evert, A., Hirsch, I. B., Murad, M. H., Winter, W. E., & Wolpert, H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2534 · Cited by 250
Forlenza, G. P., Li, Z., Buckingham, B. A., Pinsker, J. E., Cengiz, E., Wadwa, R. P., Ekhlaspour, L., Church, M. M., Weinzimer, S. A., Jost, E., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0771 · Cited by 246 · cited 1×
“2% with sensor-augmented pump therapy without predictive low glucose suspend) without rebound hyperglycemia during a 6-week randomized crossover trial (120).”
MethodReddy, M., Jugnee, N., El Laboudi, A., Spanudakis, E., Anantharaja, S., & Oliver, N. (2018) · Diabetic Medicine · doi:10.1111/dme.13561 · Cited by 245
Yoo, H. J., An, H. G., Park, S. Y., Ryu, O. H., Kim, H. Y., Seo, J. A., Hong, E. G., Shin, D. H., Kim, Y. H., Kim, S. G., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.015 · Cited by 244 · cited 3×
“The findings in studies withMDI alone (50) and in two studies in people using oral agents with or without insulin (48,49) showed significant reductions in A1C levels.”
BackgroundMethodMaahs, D. M., Hermann, J. M., Holman, N., Foster, N. C., Kapellen, T. M., Allgrove, J., Schatz, D. A., Hofer, S. E., Campbell, F., Steigleder-Schweiger, C., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0780 · Cited by 224
Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes
Plotnick, L. P., Clark, L. M., Brancati, F. L., & Erlinger, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1142 · Cited by 216
The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes
Secher, A. L., Ringholm, L., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2013) · Diabetes Care · doi:10.2337/dc12-2360 · Cited by 214
Mauras, N., Beck, R., Xing, D., Ruedy, K., Buckingham, B., Tansey, M., White, N. H., Weinzimer, S. A., Tamborlane, W., Kollman, C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1746 · Cited by 204
Ehrhardt, N. M., Chellappa, M., Walker, M. S., Fonda, S. J., & Vigersky, R. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500320 · Cited by 199 · cited 3×
“The findings in studies withMDI alone (50) and in two studies in people using oral agents with or without insulin (48,49) showed significant reductions in A1C levels.”
BackgroundMethodHerman, A., Aerts, O., Baeck, M., Bruze, M., De Block, C., Goossens, A., Hamnerius, N., Huygens, S., Maiter, D., Tennstedt, D., et al. (2017) · Contact Dermatitis · doi:10.1111/cod.12866 · Cited by 192
Barnard, K. D., Wysocki, T., Allen, J. M., Elleri, D., Thabit, H., Leelarathna, L., Gulati, A., Nodale, M., Dunger, D. B., Tinati, T., et al. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000025 · Cited by 159
Young, L. A., Buse, J. B., Weaver, M. A., Vu, M. B., Mitchell, C. M., Blakeney, T., Grimm, K., Rees, J., Niblock, F., Donahue, K. E., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.1233 · Cited by 148
Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors
Klonoff, D. C., Parkes, J. L., Kovatchev, B. P., Kerr, D., Bevier, W. C., Brazg, R. L., Christiansen, M., Bailey, T. S., Nichols, J. H., & Kohn, M. A. (2018) · Diabetes Care · doi:10.2337/dc17-1960 · Cited by 144
Sepah, S. C., Jiang, L., & Peters, A. L. (2014) · The Diabetes Educator · doi:10.1177/0145721714531339 · Cited by 139
Sherr, J. L., Cengiz, E., Palerm, C. C., Clark, B., Kurtz, N., Roy, A., Carria, L., Cantwell, M., Tamborlane, W. V., & Weinzimer, S. A. (2013) · Diabetes Care · doi:10.2337/dc13-0010 · Cited by 125 · cited 1×
“Emerging evidence suggests such systems may lower the risk of exerciserelated hypoglycemia (123) and may”
BackgroundFleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetologia · doi:10.1007/s00125-019-05034-1 · Cited by 125
Tumminia, A., Crimi, S., Sciacca, L., Buscema, M., Frittitta, L., Squatrito, S., Vigneri, R., & Tomaselli, L. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2557 · Cited by 100 · cited 1×
“real-time CGM device resulted in a greater likelihood of an improvement in glycemic control (32,36).”
BackgroundWEI, Q., SUN, Z., YANG, Y., YU, H., DING, H., & WANG, S. (2016) · Scientific Reports · doi:10.1038/srep19920 · Cited by 99
Treat-to-target trials: uses, interpretation and review of concepts
Garber, A. J. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12129 · Cited by 94 · cited 1×
“However, for patients using basal insulin, assessing fasting glucose with SMBG to inform dose adjustments to achieve blood glucose targets results in lower A1C (8,9).”
BackgroundMannucci, E., Antenore, A., Giorgino, F., & Scavini, M. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817719290 · Cited by 90 · cited 1×
“structured diabetes therapy adjustment (17).”
Haynes, A., Hermann, J. M., Miller, K. M., Hofer, S. E., Jones, T. W., Beck, R. W., Maahs, D. M., Davis, E. A., Holl, R. W., & for the T1D Exchange, W. A. D. R. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12477 · Cited by 88
Bergenstal, R. M., Johnson, M., Passi, R., Bhargava, A., Young, N., Kruger, D. F., Bashan, E., Bisgaier, S. G., Isaman, D. J. M., & Hodish, I. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30368-x · Cited by 88
Kamann, S., Aerts, O., & Heinemann, L. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818762946 · Cited by 85
Paris, I., Henry, C., Pirard, F., Gérard, A., & Colin, I. M. (2018) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.23 · Cited by 84
Tsalikian, E., Fox, L., Weinzimer, S., Buckingham, B., White, N. H., Beck, R., Kollman, C., Xing, D., Ruedy, K., & Diabetes Research in Children Network (DirecNet) Study Group (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00837.x · Cited by 83
Chao, D. Y., Lin, T. M., & Ma, W.-Y. (2019) · JMIR Diabetes · doi:10.2196/11017 · Cited by 82
Lin, M. H., Connor, C. G., Ruedy, K. J., Beck, R. W., Kollman, C., Buckingham, B., Redondo, M. J., Schatz, D., Haro, H., Lee, J. M., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0132 · Cited by 81
Evidence-based mHealth chronic disease mobile app intervention design: Development of a framework
Wilhide III, C. C., Peeples, M. M., & Anthony Kouyaté, R. C. (2016) · JMIR Research Protocols · doi:10.2196/resprot.4838 · Cited by 81
Continuous glucose monitoring in patients with type 1 diabetes using insulin injections
Foster, N. C., Miller, K. M., Tamborlane, W. V., Bergenstal, R. M., & Beck, R. W. (2016) · Diabetes Care · doi:10.2337/dc16-0207 · Cited by 76
Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry
Wong, J. C., Boyle, C., DiMeglio, L. A., Mastrandrea, L. D., Abel, K.-L., Cengiz, E., Cemeroglu, P. A., Aleppo, G., Largay, J. F., Foster, N. C., et al. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816663963 · Cited by 69
Anderson, S. M., Buckingham, B. A., Breton, M. D., Robic, J. L., Barnett, C. L., Wakeman, C. A., Oliveri, M. C., Brown, S. A., Ly, T. T., Clinton, P. K., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0018 · Cited by 68
Riddlesworth, T., Price, D., Cohen, N., & Beck, R. W. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0281-4 · Cited by 65
Opipari-Arrigan, L., Fredericks, E. M., Burkhart, N., Dale, L., Hodge, M., & Foster, C. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00283.x · Cited by 64 · cited 17×
“There is also evidence that CSII may reduce DKA risk (109,114) and diabetes complications, in particular, retinopathy and peripheral neuropathy in youth, compared with MDI (62).”
BackgroundInfluentialInsulin pump-associated adverse events in children and adolescents–a prospective study
Wheeler, B. J., Heels, K., Donaghue, K. C., Reith, D. M., & Ambler, G. R. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0388 · Cited by 64 · cited 1×
“tients at risk for ketosis andDKA and thus must be recognized and managed early (97); lipohypertrophy or, less frequently, lipoatrophy (98,99); and pump site infection (100).”
BackgroundAlemzadeh, R., Ellis, J. N., Holzum, M. K., Parton, E. A., & Wyatt, D. T. (2004) · Pediatrics · doi:10.1542/peds.114.1.e91 · Cited by 63
Lasalvia, P., Barahona-Correa, J. E., Romero-Alvernia, D. M., Gil-Tamayo, S., Castañeda-Cardona, C., Bayona, J. G., Triana, J. J., Laserna, A. F., Mejía-Torres, M., Restrepo-Jimenez, P., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633721 · Cited by 63
Pintus, D., & Ng, S. M. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.054 · Cited by 60
A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice
Bailey, T. S., & Stone, J. Y. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1313831 · Cited by 60
Beato-Víbora, P. I., Quirós-López, C., Lázaro-Martín, L., Martín-Frías, M., Barrio-Castellanos, R., Gil-Poch, E., Arroyo-Díez, F. J., & Giménez-Álvarez, M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0199 · Cited by 60 · cited 1×
“been performed, in adults and children, showing the benefits of this technology (121,122).”
BackgroundContinuous glucose monitoring pilot in low-income type 1 diabetes patients
Sequeira, P. A., Montoya, L., Ruelas, V., Xing, D., Chen, V., Beck, R., & Peters, A. L. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0072 · Cited by 59
Berghaeuser, M., Kapellen, T., Heidtmann, B., Haberland, H., Klinkert, C., Holl, R., & for the DPV-Science-Initiative and the German working group for insulin pump treatment in paediatric patients (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00416.x · Cited by 58
Wong, J. C., Dolan, L. M., Yang, T. T., & Hood, K. K. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12221 · Cited by 53
Landau, Z., Abiri, S., Gruber, N., Levy-Shraga, Y., Brener, A., Lebenthal, Y., Barash, G., Pinhas-Hamiel, O., & Rachmiel, M. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1218-8 · Cited by 48
Pleus, S., Ulbrich, S., Zschornack, E., Kamann, S., Haug, C., & Freckmann, G. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0171 · Cited by 47 · cited 1×
“all devices that attach to the skin (71).”
Psychosocial impact of the bionic pancreas during summer camp
Weissberg-Benchell, J., Hessler, D., Polonsky, W. H., & Fisher, L. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816640289 · Cited by 47
Öberg, U., Isaksson, U., Jutterström, L., Orre, C. J., & Hörnsten, Å. (2018) · JMIR Diabetes · doi:10.2196/diabetes.9059 · Cited by 41
Hermanns, N., Schumann, B., Kulzer, B., & Haak, T. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814524105 · Cited by 39
A review of blood glucose monitor accuracy
King, F., Ahn, D., Hsiao, V., Porco, T., & Klonoff, D. C. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0232 · Cited by 37 · cited 1×
“There is substantial variation in the accuracy of widely used blood glucose monitoring systems (20).”
BackgroundTroncone, A., Bonfanti, R., Iafusco, D., Rabbone, I., Sabbion, A., Schiaffini, R., Galderisi, A., Marigliano, M., Rapini, N., Rigamonti, A., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1073 · Cited by 33
Evaluation of flash glucose monitoring after long-term use: a pediatric survey
Vergier, J., Samper, M., Dalla-Vale, F., Ventura, V., Baucher, F., Joubert, F., Pons, C., De Oliveira, M., Salet, R., Faure-Galon, N., et al. (2019) · Primary Care Diabetes · doi:10.1016/j.pcd.2018.08.004 · Cited by 32
Wong, J. C., Izadi, Z., Schroeder, S., Nader, M., Min, J., Neinstein, A. B., & Adi, S. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0251 · Cited by 29 · cited 1×
“for monitoring patients, both by the patients themselves as well as their healthcareteam(143).”
BackgroundMcGill, D. E., Volkening, L. K., Butler, D. A., Wasserman, R. M., Anderson, B. J., & Laffel, L. M. (2019) · Diabetic Medicine · doi:10.1111/dme.13929 · Cited by 27
FreeStyle Libre: contact irritation versus contact allergy
Aerts, O., Herman, A., Bruze, M., Goossens, A., & Mowitz, M. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32142-6 · Cited by 24
Sai, S., Urata, M., & Ogawa, I. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818821664 · Cited by 20
Disposable insulin syringe reuse and aseptic practices in diabetic patients
Thomas, D. R., Fischer, R. G., Nicholas, W. C., Beghe, C., Hatten, K. W., & Thomas, J. N. (1989) · Journal of General Internal Medicine · doi:10.1007/bf02602347 · Cited by 19 · cited 1×
“reused by the same individual in resourcelimited settings with appropriate storage and cleansing (81).”
BackgroundUsing digital health technology to prevent and treat diabetes
Kaufman, N., Ferrin, C., & Sugrue, D. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.2506 · Cited by 17
Insulin pens in elderly diabetic patients
Reinauer, K.-M., Joksch, G., Renn, W., & Eggstein, M. (1990) · Diabetes Care · doi:10.2337/diacare.13.11.1136 · Cited by 15
Gill, M., Chhabra, H., Shah, M., Zhu, C., & Grunberger, G. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0220 · Cited by 8
Cited by
Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas
Kesavadev, J., Saboo, B., Krishna, M. B., & Krishnan, G. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00831-z · Cited by 221
Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus
Lin, R., Brown, F., James, S., Jones, J., & Ekinci, E. (2021) · Diabetic Medicine · doi:10.1111/dme.14528 · Cited by 197
Advanced Diabetes Management Using Artificial Intelligence and Continuous Glucose Monitoring Sensors
Vettoretti, M., Cappon, G., Facchinetti, A., & Sparacino, G. (2020) · Sensors · doi:10.3390/s20143870 · Cited by 176
“Nevertheless, the use of an insulin pump may prove to be burdensome for some patients [22], and the majority of patients with insulin-dependent diabetes still rely on multiple daily injection (MDI) therapy, in which the patient manually injects insulin doses using insulin pens or syringes.”
BackgroundMobile and Wearable Technology for the Monitoring of Diabetes-Related Parameters: Systematic Review
Rodriguez-León, C., Villalonga, C., Munoz-Torres, M., Ruiz, J. R., & Banos, O. (2021) · JMIR mHealth and uHealth · doi:10.2196/25138 · Cited by 132
Eberle, C., & Stichling, S. (2021) · Journal of Medical Internet Research · doi:10.2196/23244 · Cited by 119
Metadata
- Authors
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-12-16
- Volume
- 43
- Issue
- Supplement_1
- Pages
- S77-S88
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4230444160
- Cited by
- 250
- References
- 90
- FWCI
- 32.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.